100% agree, imo the holly grail will be the commercial launch in the second half of 2020, once trials have been completed. The HeraCARE solution will be available globally, with the initial focus on the U.S., Australia and Germany. an update in the USA distribution deal.
what im confident about is how fast HMD progress. HeraMED will now focus on initiating pilot and beta testing and clinical trials for HeraCARE several months ahead of schedule.
